Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis
Clinical trial NCT04784091 · COMPLETED
Trial details
- NCT number
- NCT04784091
- Sponsor
- Tarsus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-29
- Primary completion
- 2022-05-09
- Enrollment
- 412
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.